
Keywords: PF ها; IDC; invasive ductal carcinoma; IL-35; interleukin-35; Tregs; regulatory T cells; TILs; tumor-infiltrating lymphocytes; EBI3; Epstein-Barr Virus (EBV)-induced gene 3; Bregs; regulatory B cells; PFS; progression-free survival; OS; overall survival; ER; est